Thursday, December 01, 2016 3:24:49 PM
open high low close
12/01/16 3.97 4.00 3.70 3.89 546,053
11/30/16 4.00 4.0799 3.81 3.97 672,460
11/29/16 4.13 4.19 3.90 4.00 1,087,235
11/28/16 4.00 4.28 3.85 4.13 2,807,527
11/25/16 3.74 3.8825 3.645 3.88 572,928
11/23/16 3.63 3.8499 3.31 3.75 1,972,045
11/22/16 3.94 4.00 3.38 3.40 4,877,070
11/21/16 3.28 3.33 3.17 3.29 280,531
11/18/16 3.20 3.28 3.20 3.28 242,802
11/17/16 3.15 3.2757 3.11 3.20 217,871
11/16/16 3.28 3.35 3.17 3.22 373,052
11/15/16 3.21 3.2716 3.19 3.26 256,690
11/14/16 3.32 3.4799 3.17 3.21 441,721
11/11/16 3.20 3.30 3.17 3.27 370,692
11/10/16 3.33 3.33 3.12 3.21 474,397
11/09/16 2.90 3.265 2.82 3.23 738,695
11/08/16 2.88 3.10 2.88 3.01 468,181
11/07/16 2.94 2.94 2.85 2.91 288,675
11/04/16 2.78 2.92 2.77 2.84 332,273
11/03/16 2.77 2.98 2.77 2.77 370,935
11/02/16 3.07 3.07 2.76 2.78 653,265
11/01/16 2.93 3.08 2.79 3.06 663,104
10/31/16 2.94 2.9599 2.76 2.79 431,858
10/28/16 2.91 3.05 2.86 2.96 439,474
10/27/16 3.08 3.09 2.82 2.95 937,106
10/26/16 3.10 3.13 3.06 3.08 440,744
10/25/16 3.29 3.34 3.10 3.13 500,121
10/24/16 3.34 3.34 3.25 3.29 353,712
10/21/16 3.30 3.36 3.28 3.33 467,905
10/20/16 3.30 3.36 3.28 3.36 285,946
10/19/16 3.47 3.47 3.27 3.32 508,662
10/18/16 3.37 3.40 3.26 3.37 378,715
10/17/16 3.30 3.32 3.2001 3.29 364,173
10/14/16 3.43 3.43 3.26 3.32 538,373
10/13/16 3.12 3.53 3.10 3.42 1,544,460
10/12/16 3.21 3.259 3.1307 3.17 539,711
10/11/16 3.37 3.37 3.19 3.23 645,158
10/10/16 3.22 3.40 3.20 3.39 736,258
10/07/16 3.60 3.6104 3.2201 3.25 1,561,105
10/06/16 3.75 3.80 3.56 3.59 1,272,270
10/05/16 4.15 4.28 3.7201 3.77 4,649,028
10/04/16 3.71 3.71 3.51 3.67 912,878
10/03/16 3.65 3.72 3.5389 3.63 857,056
09/30/16 3.83 3.89 3.50 3.63 1,534,932
09/29/16 4.00 4.00 3.70 3.75 3,333,009
09/28/16 4.05 4.88 4.00 4.13 27,048,530
09/27/16 3.20 3.21 3.06 3.14 842,861
09/26/16 3.13 3.19 3.01 3.15 1,060,037
09/23/16 3.22 3.24 3.02 3.11 2,101,679
09/22/16 3.00 3.54 2.90 3.28 11,286,380
09/21/16 2.64 2.66 2.43 2.61 652,926
09/20/16 2.97 2.97 2.61 2.64 759,355
09/19/16 2.50 2.60 2.50 2.60 366,024
09/16/16 2.50 2.56 2.46 2.51 376,139
09/15/16 2.56 2.5775 2.45 2.50 388,800
09/14/16 2.61 2.6457 2.46 2.55 537,469
09/13/16 3.01 3.0175 2.4801 2.58 1,748,000
09/12/16 3.01 3.08 3.01 3.01 607,594
09/09/16 3.05 3.09 3.01 3.01 394,228
09/08/16 3.05 3.09 3.031 3.06 162,144
09/07/16 3.04 3.10 3.03 3.06 262,541
09/06/16 3.04 3.0599 3.01 3.04 353,714
09/02/16 3.05 3.07 3.03 3.05 270,643
09/01/16 3.10 3.21 3.01 3.03 736,817
08/31/16 3.05 3.08 3.03 3.06 337,463
08/30/16 3.04 3.14 3.04 3.05 249,356
08/29/16 3.06 3.0782 3.03 3.04 424,310
08/26/16 3.15 3.16 3.00 3.04 787,379
08/25/16 3.15 3.20 3.13 3.14 459,761
08/24/16 3.28 3.33 3.15 3.18 528,632
08/23/16 3.21 3.32 3.18 3.26 247,817
08/22/16 3.25 3.26 3.1701 3.21 259,194
08/19/16 3.30 3.35 3.20 3.21 404,728
08/18/16 3.24 3.429 3.15 3.32 437,158
08/17/16 3.30 3.37 3.14 3.26 480,612
08/16/16 3.51 3.51 3.30 3.32 525,897
08/15/16 3.79 3.88 3.3901 3.54 1,470,505
08/12/16 3.23 3.78 3.10 3.70 3,526,493
08/11/16 3.10 3.16 3.00 3.02 677,875
08/10/16 3.04 3.0802 3.00 3.03 516,663
08/09/16 3.13 3.20 3.03 3.06 771,446
08/08/16 3.45 3.50 3.16 3.17 886,932
08/05/16 3.25 3.58 3.25 3.42 1,065,857
08/04/16 3.14 3.58 3.11 3.38 1,675,711
08/03/16 3.21 3.29 2.91 3.11 1,881,652
08/02/16 3.51 3.58 3.24 3.37 1,359,123
08/01/16 3.90 3.97 3.56 3.61 1,326,802
07/29/16 3.70 4.00 3.535 3.84 3,361,301
07/28/16 4.02 4.40 3.46 3.51 5,035,328
07/27/16 7.55 7.60 4.08 4.46 10,427,270
07/26/16 7.54 7.61 7.09 7.49 1,046,066
07/25/16 7.45 7.82 7.18 7.46 1,776,576
07/22/16 7.10 7.37 6.75 6.86 987,258
07/21/16 7.12 7.32 7.00 7.11 699,186
07/20/16 7.05 7.31 7.05 7.16 515,479
07/19/16 7.41 7.66 6.90 7.00 1,025,735
07/18/16 7.05 7.49 7.00 7.37 898,480
07/15/16 6.80 7.17 6.70 7.06 783,633
07/14/16 7.00 7.07 6.6201 6.80 1,282,758
07/13/16 7.44 7.60 7.06 7.10 1,177,831
07/12/16 7.48 7.84 7.10 7.62 1,652,984
07/11/16 7.65 8.30 7.43 7.73 2,398,376
07/08/16 6.91 8.00 6.78 7.58 1,958,452
07/07/16 6.37 6.99 6.3001 6.94 1,140,912
07/06/16 6.26 6.40 6.03 6.30 643,553
07/05/16 5.80 6.47 5.66 6.26 1,041,884
07/01/16 6.17 6.17 5.60 5.89 1,225,463
06/30/16 5.61 6.11 5.393 6.11 2,150,989
06/29/16 5.22 5.25 4.84 5.25 858,751
06/28/16 4.76 4.8092 4.60 4.78 428,227
06/27/16 4.60 4.66 4.37 4.54 553,788
06/24/16 4.08 4.63 4.06 4.55 3,614,858
06/23/16 4.15 4.39 4.13 4.27 524,940
06/22/16 4.30 4.32 4.07 4.15 457,538
06/21/16 4.32 4.32 4.01 4.23 362,384
06/20/16 4.06 4.18 4.03 4.11 272,120
06/17/16 4.28 4.28 4.02 4.02 272,440
06/16/16 4.16 4.30 4.05 4.29 346,415
06/15/16 4.09 4.16 4.01 4.15 170,530
06/14/16 4.05 4.14 3.95 4.08 292,210
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM

